The Working Party deals with EU law relating to the regulatory requirements for market access of pharmaceuticals and medical devices and their surveillance and vigilance once they are marketed. Its legislative work handles issues related to clinical trials and requirements for authorisations of pharmaceuticals and of special categories of medicinal products (such as orphan medicines and paediatric medicines) and requirements for placing medical devices on the market.
Next meetings: